These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 20874834)

  • 1. Cost-effectiveness of screening for hepatocellular carcinoma among subjects at different levels of risk.
    Chang Y; Lairson DR; Chan W; Lu SN; Aoki N
    J Eval Clin Pract; 2011 Apr; 17(2):261-7. PubMed ID: 20874834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiviral therapy for hepatitis B-related liver cancer prevention is more cost-effective than cancer screening.
    Robotin MC; Kansil M; Howard K; George J; Tipper S; Dore GJ; Levy M; Penman AG
    J Hepatol; 2009 May; 50(5):990-8. PubMed ID: 19303657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Screening for the early diagnosis of hepatocellular carcinoma: cost-effectiveness analysis].
    Bolondi L; Gaiani S; Casali A; Serra C; Piscaglia F
    Radiol Med; 1997; 94(1-2):4-7. PubMed ID: 9424649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural history of chronic hepatitis B REVEALed.
    Chen CJ; Yang HI
    J Gastroenterol Hepatol; 2011 Apr; 26(4):628-38. PubMed ID: 21323729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatocellular carcinoma development in cirrhosis.
    Okuda H
    Best Pract Res Clin Gastroenterol; 2007; 21(1):161-73. PubMed ID: 17223503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for hepatocellular carcinoma.
    Merican I
    Med J Malaysia; 1996 Mar; 51(1):12-7. PubMed ID: 10967973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical prognostic variables in young patients (under 40 years) with hepatitis B virus-associated hepatocellular carcinoma.
    Wang Q; Luan W; Villanueva GA; Rahbari NN; Yee HT; Manizate F; Hiotis SP
    J Dig Dis; 2012 Apr; 13(4):214-8. PubMed ID: 22435506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of surveillance programs for hepatocellular carcinoma in the Asia-Pacific Region.
    Amarapurkar D; Han KH; Chan HL; Ueno Y;
    J Gastroenterol Hepatol; 2009 Jun; 24(6):955-61. PubMed ID: 19383082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombocytopenia as a surrogate for cirrhosis and a marker for the identification of patients at high-risk for hepatocellular carcinoma.
    Lu SN; Wang JH; Liu SL; Hung CH; Chen CH; Tung HD; Chen TM; Huang WS; Lee CM; Chen CC; Changchien CS
    Cancer; 2006 Nov; 107(9):2212-22. PubMed ID: 17019738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of hepatocellular carcinoma in the Asia-Pacific region: consensus statements.
    Asia-Pacific Working Party on Prevention of Hepatocellular Carcinoma
    J Gastroenterol Hepatol; 2010 Apr; 25(4):657-63. PubMed ID: 20492323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening and early treatment of migrants for chronic hepatitis B virus infection is cost-effective.
    Veldhuijzen IK; Toy M; Hahné SJ; De Wit GA; Schalm SW; de Man RA; Richardus JH
    Gastroenterology; 2010 Feb; 138(2):522-30. PubMed ID: 19879275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Occult hepatitis B virus infection is associated with the development of hepatocellular carcinoma in chronic hepatitis C patients.
    Squadrito G; Pollicino T; Cacciola I; Caccamo G; Villari D; La Masa T; Restuccia T; Cucinotta E; Scisca C; Magazzu D; Raimondo G
    Cancer; 2006 Mar; 106(6):1326-30. PubMed ID: 16453330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The significance of anti-HBc and occult hepatitis B virus infection in the occurrence of hepatocellular carcinoma in patients with HBsAg and anti-HCV negative alcoholic cirrhosis].
    Kim MJ; Kwon OS; Chung NS; Lee SY; Jung HS; Park DK; Ku YS; Kim YK; Kim YS; Kim JH
    Korean J Hepatol; 2008 Mar; 14(1):67-76. PubMed ID: 18367859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carriers of inactive hepatitis B virus are still at risk for hepatocellular carcinoma and liver-related death.
    Chen JD; Yang HI; Iloeje UH; You SL; Lu SN; Wang LY; Su J; Sun CA; Liaw YF; Chen CJ;
    Gastroenterology; 2010 May; 138(5):1747-54. PubMed ID: 20114048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of c-kit protooncogen in hepatitis B virus-induced chronic hepatitis, cirrhosis and hepatocellular carcinoma: has it a diagnostic role?
    Kara B; Doran F; Kara IO; Akkiz H; Sandikci M
    Int J Clin Pract; 2008 Aug; 62(8):1206-11. PubMed ID: 18284441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatocellular cancer: optimal strategies for screening and surveillance.
    Cabibbo G; Craxì A
    Dig Dis; 2009; 27(2):142-7. PubMed ID: 19546552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cost-effectiveness of alternative strategies against HBV in Italy.
    Ruggeri M; Cicchetti A; Gasbarrini A
    Health Policy; 2011 Sep; 102(1):72-80. PubMed ID: 21035229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for hepatocellular carcinoma in patients with cirrhosis in the United States: results of a national survey.
    Chalasani N; Said A; Ness R; Hoen H; Lumeng L
    Am J Gastroenterol; 1999 Aug; 94(8):2224-9. PubMed ID: 10445554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis C virus in chronic liver disease and hepatocellular carcinoma in Taiwan.
    Chen DS
    Princess Takamatsu Symp; 1995; 25():27-32. PubMed ID: 8875606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Preneoplastic markers of hepatitis B virus-associated hepatocellular carcinoma and their significance in clinical settings].
    Tong GD; Zhou DQ; He JS; Xiao CL; Liu XL; Zhou XZ; Zhang X; Xing YF; Lü P; Feitelson MA
    Zhonghua Gan Zang Bing Za Zhi; 2007 Nov; 15(11):828-32. PubMed ID: 18073065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.